Compositions and methods for predicting response and resistance to ctla4 blockade in melanoma using a gene expression signature

Phoebe Bonner-Ferraby, Henry Hepburne-Scott, Hatem Soliman, Scott J. Antonia, Materials and methods for differential treatment of cancer ,(2013)

Michael W. Tusche, Xiuqiu Lai, Tak W. Mak, Antibodies to toso ,(2014)

Analisa Difeo, Rui Chang, Shanthi Sivendran, Yvonne Saenger, Biomarker associated with risk of melanoma reoccurrence ,(2013)

Ranjan Perera, Mir-211 expression and related pathways in human melanoma ,(2011)

Erik Depla, Andreas Gschwind, Frederik Stevenaert, Marie-Ange Buyse, Eric Borges, Joachim Boucneau, Pascal Merchiers, Rene Georg Ott, Ang2-binding molecules ,(2013)

Amy Heimberger, W.K. Alfred Yung, Charles Conrad, Candelaria Gomez-Manzano, Frank Tufaro, Juan Fueyo-Margareto, Frederick Lang, Biomarkers and combination therapies using oncolytic virus and immunomodulation ,(2013)

Christine Kuslich, David Spetzler, George Poste, Michael Klass, Traci Pawlowski, Circulating biomarkers for disease ,(2011)

Takumi Kiwamoto, Norihito Kawasaki, James C. Paulson, Bruce S. Bochner, Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. Pharmacology & Therapeutics. ,vol. 135, pp. 327- 336 ,(2012) , 10.1016/J.PHARMTHERA.2012.06.005

Jérôme Galon, Helen K. Angell, Davide Bedognetti, Francesco M. Marincola, The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures Immunity. ,vol. 39, pp. 11- 26 ,(2013) , 10.1016/J.IMMUNI.2013.07.008

Lisu Wang, Omid Hamid, Henrik Schmidt, John Cogswell, Suresh Alaparthy, David Berman, Maria Jure-Kunkel, Nathan O. Siemers, Jeffrey R. Jackson, Vafa Shahabi, Rui-Ru Ji, Scott D. Chasalow, An immune-active tumor microenvironment favors clinical response to ipilimumab Cancer Immunology, Immunotherapy. ,vol. 61, pp. 1019- 1031 ,(2012) , 10.1007/S00262-011-1172-6